3Janssen I, Powell LH, Crawford S, et al. Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation. Arch Intern Med, 2008,168 : 1568-1575. 被引量：1
4Collins P, Rosano G, Casey C, et al. Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists. Climacteric, 2007,10:508-526. 被引量：1
5Panjari M, Davis SR. DHEA for postmenopausal women:a review of the evidence. Maturitas,2010,66 : 172-179. 被引量：1
6Labrie F, B61anger A, Luu-The V, et al. DHEA and the intracrine formation of androgens and estrogens in peripheral target tlssues:its role during aging. Steroids, 1998,63:322-328. 被引量：1
7Payne AH, Hales DB. Overview of steroidogenie enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev, 2004,25 : 947-970. 被引量：1
8Labrie F, Luu-The V, Labrie C, et al. DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Front Neuroendoerinol, 2001,22: 185- 212. 被引量：1
9Labrie F, Martel C, Balser J. Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women : role of the ovary ? Menopause, 2011,18 : 30 43. 被引量：1
10Labrie F. Intraerinology. Mo| Cell Endocrinol, 1991,78:113- 118. 被引量：1
